The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation

European Journal of Pharmacology

Volumn 328, Issue 1, 1997, Pages 61-64

  Williamson, David J ^a   Shepheard, Sara L ^a   Hill, Raymond G ^a   Hargreaves, Richard J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

CGRP (calcitonin gene related peptide); Intravital; Meningeal artery; Microscopy; Middle; Migraine; Rizatriptan

Indexed keywords

ANTIMIGRAINE AGENT; CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; RIZATRIPTAN; SEROTONIN 1 AGONIST; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGEAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0030902898     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83028-2     Document Type: Article

References (12)

1. 1B receptor messenger RNA in rat brain and trigeminal ganglia. Br. J. Pharmacol. 108:1993;95P.
2. Connor, H.E., Beattie, D.T., 1996. 5-Hydroxytryptamine receptor subtypes and migraine. In: Sandler, M., Ferrari, M., Harnett, S. (Eds.), Migraine: Pharmacology and Genetics. Chapman&Hall, London, pp. 18-31.
3. Edvinsson L., Goadsby P.J. Neuropeptides in migraine and cluster headache. Cephalalgia. 14:1994;320-327.
4. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterising cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33:1993;48-56.
5. 1 receptor agonist CP-122,288, a selective inhibitor of neurogenic inflammation. Br. J. Pharmacol. 116:1995;2385-2390.
6. Humphrey P.P.A., Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci. 12:1991;444-446.
7. Kurosawa M., Messlinger K., Pawlak M., Schmidt R.F. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br. J. Pharmacol. 114:1995;1397-1402.
8. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13:1992;307-311.
9. Ray B.S., Wolff H.G. Experimental studies on headache: pain sensitive structures of the head and their significance in headache. Arch. Surg. 41:1940;813-856.
10. 1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
11. Visser W.H., Terwindt G.M., Reines S.A., Jiang K., Lines C.R., Ferrari M.D. Rizatriptan vs. sumatriptan in the acute treatment of migraine: a placebo-controlled, dose-ranging study. Arch. Neurol. 53:1996;1132-1137.
12. Williamson D.J., Hargreaves R.J., Hill R.G., Shepheard S.L. Direct measurement of dural vessel diameter in the rat using intravital microscopy. Br. J. Pharmacol. 117:1996;271P.